Optimized Carnitine

Optimized Carnitine

Life Extension4.8 (1,275 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 30 servings
Goals
$23.25 $0.77 per serving

Product analysis

52 out of 100

Optimized Carnitine combines carnitines involved in cellular energy processes. Its focus-related evidence comes from other populations and longer use, so an immediate benefit for healthy adults is uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The carnitine forms are unspecified, limiting a clear quality comparison. Their names alone do not establish interchangeable preparations or amounts.

Ingredient Transparency63

The listed amounts are identified, but the forms are unspecified. That makes serving quantities clearer than the precise preparations.

Value For Money60

The main acetyl L-carnitine content offers reasonably favorable value. Value for the separately named carnitine entry remains uncertain, so the conclusion does not extend to every declaration.

Customer Satisfaction83

Customer ratings are very positive across more than a thousand reviews. That provides a broad picture of satisfaction without establishing immediate focus or energy benefits.

Product Focus60

The carnitines have a connection to cellular energy, but routine cognitive or fatigue benefits in healthy adults are uncertain. The many associated goals extend beyond what those normal biological roles establish.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.77
Customer rating
4.8 · 1,275 ratings
Report analysis

Goals

Metabolism Support
Impact
Lower effect
C Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 800 mg
Study evidence
Energy
Impact
High effect
C- Ingredient FitD PathwaysA+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 800 mg
Study evidence
Mental Focus
Impact
High effect
B Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 800 mg
Study evidence
Brain Health
Impact
High effect
B Ingredient FitC- PathwaysB EvidenceA+ Formulation Logic
Study evidence
Longevity
Impact
Moderate effect
B Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic
Study evidence
Cognitive Support
Impact
High effect
B Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 800 mg
Study evidence

Ingredients

IngredientAmount per servingScore
Acetyl L-Carnitine HCl
800 mg 79
Acetyl L-Carnitine Arginate Di-HCl
300 mg
Glycine Propionyl L-Carnitine HCl
300 mg
Adults 18–50
Report overview
Acetyl L-Carnitine · 800 mg OverallScore79
C- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB Value
The serving provides 1100 mg of acetyl L-carnitine HCl, with a relatively low whole-product cost for that amount. Other carnitine is also present, but its proportion is unclear. The available information does not mention cGMP manufacturing or purity testing.
How this ingredient is rated

Active Ingredient Quality & Bioavailability59

The ingredient is acetyl L-carnitine HCl. Other carnitine is also present, but its proportion is unclear. The available information does not mention cGMP manufacturing or purity testing.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is present alongside another carnitine; their proportions are unclear.
Advanced Sourcing and Salt Specificity
The HCl salt form is specified. The available information does not mention cGMP manufacturing or purity testing.

Dose, Safety & Label Transparency100

The serving provides 1100 mg of acetyl L-carnitine.
Clinical Dosage Efficacy
The serving provides 1100 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The acetyl L-carnitine amount is stated as 1100 mg per serving.

Value75

The whole-product cost is relatively low relative to its acetyl L-carnitine amount.
Price per 500mg Acetyl L-Carnitine
The whole-product cost is relatively low relative to its acetyl L-carnitine amount.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  7. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  8. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  9. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  10. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  11. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  12. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  13. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsLongevity forAcetyl L-Carnitine
  14. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  15. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  16. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  17. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  18. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Support forAcetyl L-Carnitine